Cargando…

Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas

The majority of hypoxic cells in squamous cell carcinomas of the head and neck and cervix express involucrin, a molecular marker for differentiation. This raises the question of whether involucrin is an oxygen-regulated protein and, if so, whether it could serve as an endogenous marker for tumour hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, S-C, Azuma, Y, Varia, M A, Raleigh, J A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409601/
https://www.ncbi.nlm.nih.gov/pubmed/14760391
http://dx.doi.org/10.1038/sj.bjc.6601585
_version_ 1782155808555925504
author Chou, S-C
Azuma, Y
Varia, M A
Raleigh, J A
author_facet Chou, S-C
Azuma, Y
Varia, M A
Raleigh, J A
author_sort Chou, S-C
collection PubMed
description The majority of hypoxic cells in squamous cell carcinomas of the head and neck and cervix express involucrin, a molecular marker for differentiation. This raises the question of whether involucrin is an oxygen-regulated protein and, if so, whether it could serve as an endogenous marker for tumour hypoxia. Consistent with oxygen regulation, involucrin protein was found to increase with increasing hypoxia in confluent cultures of moderately differentiated human SCC9 cells. Cells harvested at the point of confluence and exposed to graded concentrations of oxygen revealed a K(m) of approximately 15 mmHg for involucrin induction. This is similar to K(m)s for HIF-1α, CAIX and VEGF. Involucrin induction showed a steep dependence on pO(2) with a transition from minimum to maximum expression occurring over less than an order of magnitude change in pO(2). In contrast to SCC9 cells, involucrin was not induced by hypoxia in poorly differentiated SCC4 cells. It is concluded that involucrin is an oxygen-regulated protein, but that differentiation modulates its transcription status with respect to hypoxia induction.
format Text
id pubmed-2409601
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24096012009-09-10 Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas Chou, S-C Azuma, Y Varia, M A Raleigh, J A Br J Cancer Experimental Therapeutics The majority of hypoxic cells in squamous cell carcinomas of the head and neck and cervix express involucrin, a molecular marker for differentiation. This raises the question of whether involucrin is an oxygen-regulated protein and, if so, whether it could serve as an endogenous marker for tumour hypoxia. Consistent with oxygen regulation, involucrin protein was found to increase with increasing hypoxia in confluent cultures of moderately differentiated human SCC9 cells. Cells harvested at the point of confluence and exposed to graded concentrations of oxygen revealed a K(m) of approximately 15 mmHg for involucrin induction. This is similar to K(m)s for HIF-1α, CAIX and VEGF. Involucrin induction showed a steep dependence on pO(2) with a transition from minimum to maximum expression occurring over less than an order of magnitude change in pO(2). In contrast to SCC9 cells, involucrin was not induced by hypoxia in poorly differentiated SCC4 cells. It is concluded that involucrin is an oxygen-regulated protein, but that differentiation modulates its transcription status with respect to hypoxia induction. Nature Publishing Group 2004-02-09 2004-02-03 /pmc/articles/PMC2409601/ /pubmed/14760391 http://dx.doi.org/10.1038/sj.bjc.6601585 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Experimental Therapeutics
Chou, S-C
Azuma, Y
Varia, M A
Raleigh, J A
Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas
title Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas
title_full Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas
title_fullStr Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas
title_full_unstemmed Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas
title_short Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas
title_sort evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas
topic Experimental Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409601/
https://www.ncbi.nlm.nih.gov/pubmed/14760391
http://dx.doi.org/10.1038/sj.bjc.6601585
work_keys_str_mv AT chousc evidencethatinvolucrinamarkerfordifferentiationisoxygenregulatedinhumansquamouscellcarcinomas
AT azumay evidencethatinvolucrinamarkerfordifferentiationisoxygenregulatedinhumansquamouscellcarcinomas
AT variama evidencethatinvolucrinamarkerfordifferentiationisoxygenregulatedinhumansquamouscellcarcinomas
AT raleighja evidencethatinvolucrinamarkerfordifferentiationisoxygenregulatedinhumansquamouscellcarcinomas